تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
Baxter International Inc.'s published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $11.8B | |
|---|---|---|
| Revenue (ttm) | 11.5B | |
| Net income (ttm) | -1.1B | |
| EPS (ttm) | -$2.06 | |
| Shares out | 517M | |
| P/E (forward) | 11.2x | |
| Dividend | $0.04 (0.16%) | |
| Volume | 10,873,738 | |
| Beta | 0.65 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $12.15B | $10.06B | $10.36B | $10.64B | $11.24B | -1.9% |
| Gross profit | $4.72B | $3.55B | $4.15B | $3.98B | $3.38B | -8.0% |
| Operating income | $1.35B | $-2.85B | $707.0M | $14.0M | $-308.0M | — |
| Net income | $1.28B | $-2.43B | $2.66B | $-649.0M | $-957.0M | — |
| EPS (diluted) | $2.53 | $-4.83 | $5.23 | $-1.27 | $-1.87 | — |
| EBITDA | $2.19B | $-1.76B | $1.73B | $1.12B | $766.0M | -23.1% |
| R&D | $531.0M | $450.0M | $518.0M | $590.0M | $518.0M | -0.6% |
| SG&A | $2.85B | $3.10B | $2.95B | $2.97B | $2.89B | +0.4% |
Recent company headlines from major financial publishers.
Under the base path, Baxter delivers gradual operational improvements where operating margins normalize toward historical levels and international healthcare tenders sustain volume demand. Shares reach $26.92 with an estimated return of 18.1% at an assigned likelihood of 45.0%. Confirmation requires meeting forward consensus adjusted diluted earnings targets.
The bull path envisions accelerated supply chain streamlining that restores operating profitability toward sector benchmarks, enabling rapid debt repayment and multiple expansion. Under this outcome, shares reach $35.73 delivering a return of 56.7% with a probability of 25.0%. Confirmation would appear through consecutive quarterly margin beats.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 5.8% | $30.9 | $30.9 | $30.9 | $30.9 | $30.9 |
| 6.8% | $28.8 | $28.8 | $28.8 | $28.8 | $28.8 |
| 7.8% | $26.9 | $26.9 | $26.9 | $26.9 | $26.9 |
| 8.8% | $25.1 | $25.1 | $25.1 | $25.1 | $25.1 |
| 9.8% | $23.4 | $23.4 | $23.4 | $23.4 | $23.4 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
